1885. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
作者: Line Melgaard.;Anders Gorst-Rasmussen.;Deidre A Lane.;Lars Hvilsted Rasmussen.;Torben Bjerregaard Larsen.;Gregory Y H Lip.
来源: JAMA. 2015年314卷10期1030-8页
The CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack/thromboembolism [doubled], vascular disease [prior myocardial infarction, peripheral artery disease, or aortic plaque], age 65-75 years, sex category [female]) is used clinically for stroke risk stratification in atrial fibrillation (AF). Its usefulness in a population of patients with heart failure (HF) is unclear.
1899. Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.
作者: Jeffery M Klco.;Christopher A Miller.;Malachi Griffith.;Allegra Petti.;David H Spencer.;Shamika Ketkar-Kulkarni.;Lukas D Wartman.;Matthew Christopher.;Tamara L Lamprecht.;Nicole M Helton.;Eric J Duncavage.;Jacqueline E Payton.;Jack Baty.;Sharon E Heath.;Obi L Griffith.;Dong Shen.;Jasreet Hundal.;Gue Su Chang.;Robert Fulton.;Michelle O'Laughlin.;Catrina Fronick.;Vincent Magrini.;Ryan T Demeter.;David E Larson.;Shashikant Kulkarni.;Bradley A Ozenberger.;John S Welch.;Matthew J Walter.;Timothy A Graubert.;Peter Westervelt.;Jerald P Radich.;Daniel C Link.;Elaine R Mardis.;John F DiPersio.;Richard K Wilson.;Timothy J Ley.
来源: JAMA. 2015年314卷8期811-22页
Tests that predict outcomes for patients with acute myeloid leukemia (AML) are imprecise, especially for those with intermediate risk AML.
1900. Time to Epinephrine and Survival After Pediatric In-Hospital Cardiac Arrest.
作者: Lars W Andersen.;Katherine M Berg.;Brian Z Saindon.;Joseph M Massaro.;Tia T Raymond.;Robert A Berg.;Vinay M Nadkarni.;Michael W Donnino.; .
来源: JAMA. 2015年314卷8期802-10页
Delay in administration of the first epinephrine dose is associated with decreased survival among adults after in-hospital, nonshockable cardiac arrest. Whether this association is true in the pediatric in-hospital cardiac arrest population remains unknown.
|